Interferon Lambda 2 (IFNL2) Antibody

Este producto es parte de IFNL2 - interferon lambda 2
Product Graph
221€ (50 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Interferon Lambda 2 (IFNL2) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx323562
tested applications
ELISA, WB

Description

IFNL2 Antibody is a Rabbit Polyclonal against IFNL2.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
Interferon Lambda 2 (IFNL2)
Host
Rabbit
Reactivity
Human
Recommended Dilution
ELISA: 1/20000, WB: 1/500 - 1/2000. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
Unconjugated
Isotype
IgG
Purification
Purified by affinity chromatography.
Size 1
50 µg
Size 2
100 µg
Form
Liquid
Tested Applications
ELISA, WB
Buffer
PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
Q8IZJ0
Gene ID
282616
Alias
IL28A,IFNL2a,IFNL3a,IFN-lambda-2,Cytokine Zcyto20,Interleukin-28A
Background
Antibody anti-IFNL2
Status
RUO

Descripción

Interferon Lambda 2 (IFNL2), also known as IL-28A, is part of the Type III interferon family, a group of cytokines that play crucial roles in the innate immune response, particularly in antiviral defense. Type III interferons, which include IFNL1 (IL-29), IFNL2 (IL-28A), IFNL3 (IL-28B), and IFNL4, are structurally distinct from Type I interferons (e.g., IFN-α and IFN-β) but share similar antiviral functions. The key difference between Type I and Type III interferons lies in their receptor usage and the cell types they target. IFNL2 acts by stimulating the immune response primarily in epithelial cells, which form a protective barrier in various organs, including the lungs, intestines, and liver. This makes it particularly important in defending against viral infections that enter the body via mucosal surfaces, such as respiratory and gastrointestinal viruses. IFNL2 has been shown to restrict the replication of viruses like hepatitis B virus (HBV), hepatitis C virus (HCV), influenza virus, and SARS-CoV-2, making it an essential player in antiviral immunity.

Related Products

EH0194

Human IL-28A (Interleukin-28A) ELISA Kit

Ver Producto
FNab04262

IL-28A antibody

Ver Producto
Pr23018

Recombinant Human IL-28A

Ver Producto